CHMFL-EGFR-202 | Interleukin Related interleukin-related.com

Product Name :
CHMFL-EGFR-202

Search keywords :
CHMFL-EGFR-202

drugId :
null

Target Vo:
EGFR T790M

Target Vo Short Name :
EGFR T790M

Moa_Name:
EGFR T790M inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Hefei Cosource Medicine Technology

Active Company_Name :
Hefei Academy Of Physical Sciences, Chinese Academy Of Sciences

Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:
Preclinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
p27 KIP 1 Antibody
TriMethyl-Histone H3 (Lys27) Antibody
Cyclin D2 Antibody (YA789): Cyclin D2 Antibody (YA789) is a non-conjugated and Mouse origined monoclonal antibody about 33 kDa, targeting to Cyclin D2 (6E11). It can be used for WB assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts